Coletiva de imprensa: anúncio do Governo - 20/01/2021
Date:
20/01/2021
O Governador João Doria anunciou nesta quarta-feira (20) que o escritório de São Paulo na China está em contato direto com as autoridades chinesas realizando esforços para agilizar o envio dos novos insumos da vacina Coronavac para o Brasil.
“Temos que estar juntos neste momento e agradecer o apoio da China ao Brasil, especialmente neste momento de dor em que o país já perdeu a vida de 20...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Quarantine/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Blood Donors/supply & distribution, Public-Private Sector Partnerships/organization & administration, Brazilian Health Surveillance Agency, Pharmaceutical Raw Material, Immunization Programs/organization & administration, Risk Groups, Ethnicity, Health Information Management/organization & administration, Plasma/immunology, International Cooperation, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Doria, João, Sinovac Biotech, Vacivida, Vacinômetro
Coletiva de imprensa: anúncios do Governo SP - 17/12/2020
Date:
17/12/2020
O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento.
“A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Ministério da Saúde apresenta balanço do combate à COVID-19
Date:
27/11/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Financial Resources in Health/economics, Health Systems/economics, Brazil/epidemiology, Access to Essential Medicines and Health Technologies, Ventilators, Mechanical/supply & distribution, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Epidemiological Monitoring, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Polymerase Chain Reaction/statistics & numerical data, Enzyme-Linked Immunosorbent Assay/statistics & numerical data, Suicide/prevention & control, Central Nervous System Agents/supply & distribution, Social Isolation/psychology, Health Information Management, Computer Security, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Brazilian Health Surveillance Agency, Immunization Programs/organization & administration, Risk Groups, COVID-19
